1
|
Dhingra R and Vasan RS: Diabetes and the
risk of heart failure. Heart Fail Clin. 8:125–133. 2012. View Article : Google Scholar : PubMed/NCBI
|
2
|
Chen HH and Burnett JC: Natriuretic
peptides in the pathophysiology of congestive heart failure. Curr
Cardiol Rep. 2:198–205. 2000. View Article : Google Scholar : PubMed/NCBI
|
3
|
Palazzuoli A, Caputo M, Calabrò A and Nuti
R: Clinical impact of BNP and other emerging biomarkers in heart
failure evaluation and management. Minerva Cardioangiol.
60:183–194. 2012.PubMed/NCBI
|
4
|
Oremus M, Raina PS, Santaguida P, et al: A
systematic review of BNP as a predictor of prognosis in persons
with coronary artery disease. Clin Biochem. 41:260–265. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
von Bibra H and St John Sutton M: Impact
of diabetes on post-infarction heart failure and left ventricular
remodeling. Curr Heart Fail Rep. 8:242–251. 2011.PubMed/NCBI
|
6
|
Shen WF: An intriguing association between
congestive heart failure and diabetes mellitus. Chin Med J.
123:643–645. 2010.PubMed/NCBI
|
7
|
van den Hurk K, Alssema M, Kamp O, et al:
Slightly elevated B-type natriuretic peptide levels in a non-heart
failure range indicate a worse left ventricular diastolic function
in individuals with, as compared with individuals without, type 2
diabetes: the Hoorn Study. Eur J Heart Fail. 12:958–965. 2010.
|
8
|
Aguiar VB, Ochiai ME, Cardoso JN, et al:
Relationship between depression, BNP levels and ventricular
impairment in heart failure. Arq Bras Cardiol. 95:732–737.
2010.PubMed/NCBI
|
9
|
From AM, Scott CG and Chen HH: The
development of heart failure in patients with diabetes mellitus and
pre-clinical diastolic dysfunction a population-based study. J Am
Coll Cardiol. 55:300–305. 2010. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kelder JC, Cowie MR, McDonagh TA, et al:
Quantifying the added value of BNP in suspected heart failure in
general practice: an individual patient data meta-analysis. Heart.
97:959–963. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Horwich TB and Fonarow GC: Glucose,
obesity, metabolic syndrome, and diabetes relevance to incidence of
heart failure. J Am Coll Cardiol. 55:283–293. 2010. View Article : Google Scholar : PubMed/NCBI
|
12
|
Boonman LJ, Rutten FH, Cramer MJ, et al:
Early recognition of heart failure in patients with diabetes type 2
in primary care. A prospective diagnostic efficiency study. BMC
Public Health. 21:479–452. 2009. View Article : Google Scholar : PubMed/NCBI
|
13
|
Igarashi M, Jimbu Y, Hiram A and Tominaga
M: Characterization of plasma brain natriuretic peptide level in
patients with type 2 diabetes. Endocr J. 52:352–362.
2005.PubMed/NCBI
|
14
|
Albertini JP, Cohen R, Valensi P, Sachs RN
and Charniot JC: B-type natriuretic peptide, a marker of
asymptomatic left ventricular dysfunction in type 2 diabetic
patients. Diabetes Metab. 34:355–362. 2008. View Article : Google Scholar : PubMed/NCBI
|
15
|
Beer S, Golay S and Bardy D: Increased
plasma levels of N-terminal brain natriuretic peptide in type 2
diabetic patients with vascular complications. Diabetes Metab.
31:567–573. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Clerico A, Vittorini S and Passino C:
Circulating forms of the b-type natriuretic peptide prohormone:
pathophysiologic and clinical considerations. Adv Clin Chem.
58:31–44. 2012. View Article : Google Scholar : PubMed/NCBI
|
17
|
Marchant K: Diabetes and chronic kidney
disease: a complex combination. Br J Nurs. 17:356–361. 2008.
View Article : Google Scholar
|
18
|
Liu C, Agnes G, Corcuff JB, Bordenave L,
Gin H and Rigalleau V: B-type natriuretic peptide in diabetes
mellitus: the influence of chronic renal failure and food. Diabetes
Care. 28:7522005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Siebenhofer A, Ng LL, Plank J, Berghold A,
Hödl R and Pieber TR: Plasma NT-pro BNP in type 1 diabetic patients
with and without diabetic nephropathy. Diabet Med. 20:535–539.
2003. View Article : Google Scholar : PubMed/NCBI
|
20
|
Koitabashi T, Inomata T, Niwano S, et al:
Distinguishable optimal levels of plasma B-type natriuretic peptide
in heart failure management based on complicated atrial
fibrillation. Int Heart J. 46:453–464. 2005. View Article : Google Scholar
|
21
|
Yufu K, Takahashi N, Nakagawa M, Hara M,
Saikawa T and Yoshimatsu H: Brain natriuretic peptide and cardiac
autonomic function in type 2 diabetic patients. Diabetes Res Clin
Pract. 72:12–19. 2006. View Article : Google Scholar : PubMed/NCBI
|